Proxinium™ is an investigational medication
that is being used in clinical trials to treat advanced
squamous cell cancer located in the
head and neck.
and Neck Cancer Head and neck cancer is the 6th
most common cancer globally, with approximately 55,000
new cases diagnosed annually in the U.S. alone, leading
to 14,000 deaths annually
content of this site is for informational purposes only
and is not intended to replace the advice of a health care
professional. Please consult your doctor if you have any
questions regarding the information contained in this site.